MBAM
FBRX icon

Mink Brook Asset Management’s Forte Biosciences FBRX Stock Holding History

Mink Brook Asset Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-81,312
Closed -$1.22M – 46
2025
Q3 		$1.22M Buy
81,312
+42,419
+109% +$489K 0.82% 22
2025
Q2 		$503K Buy
+38,893
New +$335K 0.44% 25

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mink Brook Asset Management's FBRX Position: Q4 2025 in Review

Mink Brook Asset Management sold out of Forte Biosciences (FBRX) in Q4 2025, closing a stake of 81,312 shares — an estimated $1.22M sold.

Mink Brook Asset Management first reported a position in FBRX in Q2 2025 and held it in 2 quarters. The position peaked at $1.22M in Q3 2025. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • Mink Brook Asset Management reported no remaining Forte Biosciences position as of Q4 2025 after selling out during the quarter.
  • Mink Brook Asset Management sold 81,312 Forte Biosciences shares in Q4 2025, an estimated $1.22M.
  • Mink Brook Asset Management first reported a position in Forte Biosciences in Q2 2025 and held it in 2 quarters.
  • Mink Brook Asset Management's Forte Biosciences position peaked at $1.22M in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on Mink Brook Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.